What is JSP Pharmaceutical Manufacturing (Thailand) PCL Cash Flow from Financing?
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Mar. 2024,
JSP Pharmaceutical Manufacturing (Thailand) PCL paid฿0.00 Mil more to buy back shares than it received from issuing new shares.
It received฿3.14 Mil from issuing more debt.
It paid฿0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.
It received฿0.00 Mil from paying cash dividends to shareholders.
It spent฿4.04 Mil on other financial activities.
In all, JSP Pharmaceutical Manufacturing (Thailand) PCLspent฿0.90 Mil on financial activities for the
three
months ended in Mar. 2024.
JSP Pharmaceutical Manufacturing (Thailand) PCL Cash Flow from Financing Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
JSP Pharmaceutical Manufacturing (Thailand) PCL Cash Flow from Financing Chart
JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend
Dec19
Dec20
Dec21
Dec22
Dec23
Cash Flow from Financing
-30.38
-44.10
629.96
-64.61
82.60
JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
JSP Pharmaceutical Manufacturing (Thailand) PCL Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿20.43 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
JSP Pharmaceutical Manufacturing (Thailand) PCL's issuance of stock for the
three
months ended in Mar. 2024 was ฿0.00 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
JSP Pharmaceutical Manufacturing (Thailand) PCL's repurchase of stock for the
three
months ended in Mar. 2024 was ฿0.00 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
JSP Pharmaceutical Manufacturing (Thailand) PCL's net issuance of debt for the
three
months ended in Mar. 2024 was ฿3.14 Mil.
JSP Pharmaceutical Manufacturing (Thailand) PCL received฿3.14 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
JSP Pharmaceutical Manufacturing (Thailand) PCL's net issuance of preferred for the
three
months ended in Mar. 2024 was ฿0.00 Mil.
JSP Pharmaceutical Manufacturing (Thailand) PCL paid฿0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
JSP Pharmaceutical Manufacturing (Thailand) PCL's cash flow for dividends for the
three
months ended in Mar. 2024 was ฿0.00 Mil.
JSP Pharmaceutical Manufacturing (Thailand) PCL received฿0.00 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
JSP Pharmaceutical Manufacturing (Thailand) PCL's other financing for the
three
months ended in Mar. 2024 was ฿-4.04 Mil.
JSP Pharmaceutical Manufacturing (Thailand) PCL spent฿4.04 Mil on other financial activities.
JSP Pharmaceutical Manufacturing (Thailand) PCL Cash Flow from Financing Related Terms
Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Business Description
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BKK:JSP-F has been successfully added to your 